| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Buendia MA | |
| P433 | issue | 3 | |
| P304 | page(s) | 185-200 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Seminars in Cancer Biology | Q1908668 |
| P1476 | title | Genetics of hepatocellular carcinoma. | |
| P478 | volume | 10 |
| Q35991536 | A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. |
| Q37266967 | A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. |
| Q41472938 | A multicenter matched case-control analysis on seven polymorphisms from HMGB1 and RAGE genes in predicting hepatocellular carcinoma risk |
| Q28597820 | A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination |
| Q47443676 | A4383C and C76G SNP in Cathepsin B is respectively associated with the high risk and tumor size of hepatocarcinoma |
| Q24607045 | ARID2: a new tumor suppressor gene in hepatocellular carcinoma |
| Q81424551 | Absence of KLF6 gene mutation in 71 hepatocellular carcinomas |
| Q42735941 | Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-beta dependent fashion |
| Q37447362 | Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61. |
| Q45585418 | Allelic loss of chromosome 4q21 approximately 23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein |
| Q57205409 | Allelic loss of chromosome 4q21?23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein |
| Q39419389 | Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma |
| Q24291237 | An integrated approach in the discovery and characterization of a novel nuclear protein over-expressed in liver and pancreatic tumors |
| Q43778437 | Anticancer potential of rhamnocitrin 4'-β-D-galactopyranoside against N-diethylnitrosamine-induced hepatocellular carcinoma in rats. |
| Q46099165 | Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. |
| Q53658904 | Association Between a Variant in ADAMTS5 and the Susceptibility to Hepatocellular Carcinoma in a Chinese Han Population. |
| Q34599939 | Association of GST genetic polymorphisms with the susceptibility to hepatocellular carcinoma (HCC) in Chinese population evaluated by an updated systematic meta-analysis |
| Q33290022 | Beclin 1 mRNA strongly correlates with Bcl-XLmRNA expression in human hepatocellular carcinoma |
| Q44534101 | Beta-catenin mutations in liver tumors induced by 2-amino-3,4-dimethylimidazo[4,5-f]quinoline in CDF1 mice |
| Q36792873 | Bioinformatics analysis of the gene expression profile of hepatocellular carcinoma: preliminary results |
| Q35131908 | Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation. |
| Q45001863 | Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: possible association with an inherited disease and cancer |
| Q34565424 | Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma |
| Q33801311 | Clinical implications of hepatitis B virus mutations: recent advances |
| Q45910989 | Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53. |
| Q37220672 | Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma |
| Q35010949 | Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China |
| Q24291548 | Cloning and characterization of F-LANa, upregulated in human liver cancer |
| Q30926657 | Cloning and characterization of human IC53-2, a novel CDK5 activator binding protein. |
| Q91870878 | Co-expression analysis and ceRNA network reveal eight novel potential lncRNA biomarkers in hepatocellular carcinoma |
| Q36923010 | Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma. |
| Q36397275 | Control of cell migration: a tumour suppressor function for p53? |
| Q36543797 | Control of differentiation in progression of epithelial tumors |
| Q42091512 | Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma. |
| Q24296626 | DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control |
| Q41970979 | DLEC1 Expression Is Modulated by Epigenetic Modifications in Hepatocelluar Carcinoma Cells: Role of HBx Genotypes |
| Q36993940 | Deregulation of epigenetic mechanisms by the hepatitis B virus X protein in hepatocarcinogenesis |
| Q35664806 | Dickkopf-1 activates cell death in MDA-MB435 melanoma cells |
| Q52967770 | Diminished transcription of chromosome arm 4q is inversely related to local spreading of hepatocellular carcinoma. |
| Q36926103 | Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer |
| Q36497062 | Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. |
| Q36792334 | Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma |
| Q40312516 | Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin |
| Q38521564 | Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells |
| Q38212153 | Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression |
| Q34327140 | Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study |
| Q35010167 | Expression of beta-catenin in hepatocellular carcinoma |
| Q43649359 | Expression profiling and identification of novel genes in hepatocellular carcinomas |
| Q35721877 | Focus on hepatocellular carcinoma. |
| Q40503818 | Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma |
| Q36313998 | From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma |
| Q34389709 | From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways |
| Q73932372 | GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma |
| Q36129235 | Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors |
| Q34850055 | Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects |
| Q35851186 | Genetic alterations of hepatocellular carcinoma by random amplified polymorphic DNA analysis and cloning sequencing of tumor differential DNA fragment |
| Q33711037 | Genetic and epigenetic characteristics of human multiple hepatocellular carcinoma |
| Q40460745 | Genetic susceptibility of eight nonsynonymous polymorphisms in HLA-DRB1 gene to hepatocellular carcinoma in Han Chinese. |
| Q80581092 | Genomic instability in hepatocellular carcinoma revealed by using the random amplified polymorphic DNA method |
| Q36474291 | Genomic instability of murine hepatocellular carcinomas with low and high metastatic capacities |
| Q44559769 | Genomic progression in mouse models for liver tumors |
| Q36388400 | HBV induced carcinogenesis |
| Q46669089 | HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma |
| Q34138263 | Harnessing transposons for cancer gene discovery |
| Q44706836 | Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells. |
| Q41826006 | Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis |
| Q58021990 | Hepatitis B virus and hepatocellular carcinoma |
| Q34398029 | Hepatitis viruses and hepatocarcinogenesis |
| Q29615841 | Hepatocellular carcinoma |
| Q39460817 | Hepatocellular carcinoma: a systems biology perspective |
| Q38083250 | Human hepatocyte carcinogenesis (review). |
| Q38183539 | Hydrodynamic transfection for generation of novel mouse models for liver cancer research |
| Q34598012 | Identification of a structural motif crucial for infectivity of hepatitis B viruses |
| Q74434735 | Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma |
| Q34331690 | Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. |
| Q24292045 | Identification of two novel human dynein light chain genes, DNLC2A and DNLC2B, and their expression changes in hepatocellular carcinoma tissues from 68 Chinese patients |
| Q43037592 | Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma |
| Q33787939 | Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran |
| Q48003450 | Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer |
| Q40314768 | Insulin-like growth factor-I stimulates H4II rat hepatoma cell proliferation: dominant role of PI-3'K/Akt signaling |
| Q42166898 | Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo |
| Q40282309 | Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma |
| Q34399237 | Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression |
| Q36917485 | Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps. |
| Q38613586 | Liver cell transformation in chronic HBV infection |
| Q37889223 | Liver development and cancer formation in zebrafish. |
| Q28592004 | Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas |
| Q58814520 | Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area |
| Q44796636 | Long-term high-dose interferon-α therapy delays Hepadnavirus-related hepatocarcinogenesis in X/myc transgenic mice |
| Q38625154 | Loss of p53 and Ink4a/Arf cooperate in a cell autonomous fashion to induce metastasis of hepatocellular carcinoma cells |
| Q37843945 | Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma |
| Q33785451 | Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis |
| Q35678361 | Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers |
| Q40390047 | Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11. |
| Q33680701 | Molecular genetics of hepatocellular neoplasia. |
| Q35260040 | Molecular mechanisms underlying hepatocellular carcinoma |
| Q74543031 | Molecular pathogenesis of human hepatocellular carcinoma |
| Q36618666 | Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis |
| Q27490350 | Mouse models in liver cancer research: A review of current literature |
| Q28213290 | Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas |
| Q35094277 | Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand |
| Q39012794 | Nanomedicine in management of hepatocellular carcinoma: Challenges and opportunities |
| Q36740642 | New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system |
| Q44226601 | New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism |
| Q36519041 | New therapies for hepatocellular carcinoma. |
| Q37418293 | Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. |
| Q28246572 | Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver |
| Q40346356 | Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations |
| Q78537160 | P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells |
| Q40203803 | PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. |
| Q39377876 | PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma. |
| Q33279919 | Pleiotropic effects of PI-3' kinase/Akt signaling in human hepatoma cell proliferation and drug-induced apoptosis |
| Q37457851 | Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression |
| Q33838680 | Postgenomic technologies targeting the Wnt signaling network |
| Q53297765 | Pre-"EMT"ing key processes in liver carcinogenesis: Growing evidence for how malignant hepatocytes invade and conquer. |
| Q37564060 | Prognostic significance of p53, mTOR, c-Met, IGF-1R, and HSP70 overexpression after the resection of hepatocellular carcinoma |
| Q40061408 | Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells |
| Q40263391 | Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma |
| Q34325518 | RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts |
| Q35988103 | Rapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample pools |
| Q41008655 | Reconstitution of gene expression from a regulatory-protein-deficient hepatitis B virus genome by cell-permeable HBx protein |
| Q53391613 | Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors. |
| Q36062154 | Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels |
| Q35919507 | Relevance between HLA-DP gene rs2281388 polymorphism and hepatocellular carcinoma risk |
| Q39496866 | Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus |
| Q87195036 | Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development |
| Q38824357 | Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinoma. |
| Q34852233 | Silencing of Pokemon enhances caspase-dependent apoptosis via fas- and mitochondria-mediated pathways in hepatocellular carcinoma cells |
| Q35695493 | Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis |
| Q40750117 | Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping |
| Q35019588 | Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fischer 344 male rats. |
| Q44490652 | Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fisher 344 male rats [Mechanisms of Ageing and Development 123 (2002) 1665-1680]. |
| Q42576509 | Staging systems in hepatocellular carcinoma |
| Q35795731 | Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance. |
| Q28485238 | Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells |
| Q54340913 | Survivin T9809C, an SNP located in 3'-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma. |
| Q42695569 | Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro |
| Q35078725 | TP53 and liver carcinogenesis. |
| Q41037020 | The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma |
| Q37606028 | The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy |
| Q53644880 | The important role of ADAM8 in the progression of hepatocellular carcinoma induced by diethylnitrosamine in mice. |
| Q36419017 | The molecular diagnosis of hepatitis B virus-associated hepatocellular carcinoma. |
| Q35348787 | The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signaling |
| Q35605993 | The p53R172H mutant does not enhance hepatocellular carcinoma development and progression. |
| Q40626766 | The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis. |
| Q34540302 | The silencing of Pokemon attenuates the proliferation of hepatocellular carcinoma cells in vitro and in vivo by inhibiting the PI3K/Akt pathway |
| Q33754980 | The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication |
| Q37468111 | The transcriptomic G1-G6 signature of hepatocellular carcinoma in an Asian population: Association of G3 with microvascular invasion. |
| Q57757025 | Treatment of hepatocellular carcinoma |
| Q35111116 | Vasohibin 2 decreases the cisplatin sensitivity of hepatocarcinoma cell line by downregulating p53. |
| Q30886599 | Viral hepatitis: new data on hepatitis C infection |
| Q35080930 | WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients |
| Q24653563 | Wnt signaling: the good and the bad |
| Q80234093 | [Precancerous lesions in the cirrhotic and non-cirrhotic liver] |
| Q39255366 | miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma |
| Q37042920 | p16 Stimulates CDC42-dependent migration of hepatocellular carcinoma cells |
| Q47840456 | p53 immunostaining pattern in Brazilian patients with hepatocellular carcinoma |
| Q36143616 | siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival |
| Q35083197 | βII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin |
Search more.